Edition:
United Kingdom

Vanda Pharmaceuticals Inc (VNDA.OQ)

VNDA.OQ on NASDAQ Stock Exchange Global Market

26.14USD
6:49pm GMT
Change (% chg)

$-0.10 (-0.38%)
Prev Close
$26.24
Open
$26.24
Day's High
$26.72
Day's Low
$25.60
Volume
91,079
Avg. Vol
347,169
52-wk High
$33.39
52-wk Low
$13.80

Chart for

About

Vanda Pharmaceuticals Inc. is a biopharmaceutical company. The Company is focused on the development and commercialization of therapies to address unmet medical needs. Its product portfolio includes HETLIOZ (tasimelteon), Fanapt (iloperidone), Tradipitant (VLY-686), Trichostatin A and AQW051. It offers HETLIOZ for the treatment... (more)

Overall

Beta: 1.37
Market Cap(Mil.): $778.29
Shares Outstanding(Mil.): 44.86
Dividend: --
Yield (%): --

Financials

  VNDA.OQ Industry Sector
P/E (TTM): -- 69.71 34.39
EPS (TTM): -0.23 -- --
ROI: -7.15 9.01 14.96
ROE: -8.07 10.15 16.52

Earnings vs. Estimates